Pharmacotherapy of Diabetes: New Developments

Improving Life and Prognosis for Diabetic Patients

  • Carl Erik Mogensen

Table of contents

  1. Front Matter
    Pages i-xv
  2. Overview

    1. Jørgen Rungby, Andrew J. Krentz
      Pages 3-8
    2. Knut Borch-Johnsen
      Pages 9-16
  3. Pharmacotherapy of Diabetes

    1. Niels Møller, K. George M. M. Alberti
      Pages 31-37
    2. Carl Erik Mogensen
      Pages 39-39
    3. Guntram Schernthaner, Gerit Holger Schernthaner
      Pages 77-86
    4. Monika Shirodkar, Serge Jabbour
      Pages 87-97
    5. Henning Beck-Nielsen, Jan Erik Henriksen
      Pages 99-109
    6. Markolf Hanefeld, Frank Schaper
      Pages 143-152
  4. Treating the Comorbid Patient

    1. Bjørn Richelsen
      Pages 167-171
    2. D. John Betteridge
      Pages 173-186
  5. Diabetic Complications and Side-effects

    1. Andrew J. M. Boulton, Frank Bowling
      Pages 229-235
    2. Anders Dejgaard, Jannik Hilsted
      Pages 237-247
    3. Elisabeth R. Mathiesen, Peter Damm
      Pages 249-254
    4. Niels Ejskjaer
      Pages 261-265
    5. Lars Rejnmark
      Pages 267-269
  6. Notes from Major Pharmaceutical Companies (all major companies asked to participate)

  7. Back Matter
    Pages 283-289

About this book


In the United States, 20.8 million children and adults, 7% of the population, have diabetes. While an estimated 14.6 million have been diagnosed, 6.2 million have yet to be diagnosed. Worldwide diabetes afflicts 150 million people. The World Health Organization estimates that by 2025 that figure will double. Diabetes is responsible for more deaths than AIDS and breast cancer, combined. It is a leading cause of blindness, kidney failure, amputations, heart complications and stroke.

Treatment of Type 1 and Type diabetes has changed radically over the past few years. There are new opportunities for treating the key abnormality in diabetes, increased blood glucose, by effective agents such as new insulin preparations and oral agents.

Increasing so-called non-glycemic intervention is of prime importance. Blood pressure lowering therapies, anti-cholesterol strategies, and specific treatment related to complications is becoming increasingly important.

Pharmacotherapy of Diabetes is a unique, invaluable guide to all aspects of the pharmacological treatment of diabetes, covering basic concepts and an in-depth review of current and future therapies. This work provides an overview for the new changes in therapies that can be implemented in clinical practice and treatment of the diabetic patient.


AIDS Diabetes diabetes, pharmacotherapy, insulin insulin insulin resistance

Editors and affiliations

  • Carl Erik Mogensen
    • 1
  1. 1.Aarhus University HospitalDenmark

Bibliographic information